
About Kashmik Formulation Private Limited
Data last updated:
Kashmik Formulation Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2017PTC095077. Its GSTIN is 24AAFCN5830K1ZD (Gujarat).
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹8.78 Cr. It was formerly known as Nectarlife Care Private Limited. It is led by directors Mahadevbhai Naranbhai Patel and Nileshkumar Mahadevbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 403 Shilp Aperia Nr Landmark Hotel Iscon Ambli Road Bodakdev, Ahmedabad, Gujarat, India – 380052.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.93 Cr, a growth of 96% compared to the previous year. For the same year it recorded a net profit of ₹48.74 Lakh (net margin 1.2%) and EBITDA of ₹5.08 Cr (EBITDA margin 12.4%). Revenue has grown at a compounded annual rate (CAGR) of 178% over three years and 197% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Kashmik. As per MCA filings, the company has open charges of ₹26.7 Cr on record. Court records list 15 cases involving the company, including 12 filed by the company and 3 filed against it; 8 cases are pending. The company has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2023. Its 10 peer companies in the same principal business activity (wholesale trading) are compared by revenue, 5 larger and 5 smaller; the largest is Puyang Refractories Group Company India Private Limited with revenue of ₹40.94 Cr.
Kashmik Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0114952). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kashmikformulation.com.
Company details
Recognitions & Rankings of Kashmik Formulation
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0114952
Contact details
Kashmik Formulation Private Limited's registered office is in Ahmedabad, Gujarat. Its website is kashmikformulation.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address403 Shilp Aperia Nr Landmark Hotel Iscon Ambli Road Bodakdev, Ahmedabad, Gujarat, India – 380052
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kashmik Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Kashmik Formulation operates one associated brand: Kashmik. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Kashmik is a pharmaceutical contract manufacturer specializing in production services for the industry. | kashmikformulation.com |
Business activity
The main business activity of Kashmik Formulation is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kashmik Formulation Private Limited, buy the company report.
Financials of Kashmik Formulation Private Limited
FY 2024 filings availableKashmik Formulation Private Limited reported revenue of ₹40.93 Cr (up 96% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 197% over five years, including 96% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.08 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kashmik Formulation Private Limited, buy the company report.
Board of directors of Kashmik Formulation Private Limited
Kashmik Formulation has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahadevbhai Naranbhai Patel Also directs: Nectar Infrabuild Private Limited, Dhvija Investment Private Limited, Neerjani Fintech Private Limited and 1 more | Director | 11 Jan 2017 | 9 Years 10 Months | Current |
| Nileshkumar Mahadevbhai Patel Also directs: Nec Foods and Beverages Private Limited, Nect Life Pharma Private Limited, Nectar Infrabuild Private Limited and 5 more | Director | 11 Jan 2017 | 9 Years 10 Months | Current |
Peer comparison
Kashmik Formulation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Puyang Refractories Group Company India Private Limited | ₹40.94 Cr (FY 2025) | 68.0% | Kolkata, West Bengal, India | |||
| Daasarathy Enterprises Private Limited | ₹40.94 Cr (FY 2025) | 10.0% | Kumbakonam, Tamil Nadu, India | |||
| Tripada Healthcare Private Limited | ₹40.94 Cr (FY 2025) | 13.0% | Ahmedabad, Gujarat, India | |||
| Anand Utilities Private Limited | ₹40.93 Cr (FY 2025) | 8.0% | Jamshedpur, Jharkhand, India | |||
| Marica Agronomics Private Limited | ₹40.93 Cr (FY 2025) | 29.0% | Noida, Uttar Pradesh, India | |||
| Kashmik Formulation Private Limitedthis company | ₹40.93 Cr (FY 2025) | ₹48.74 Lakh | 1.2% | 96.0% | 22 | Ahmedabad, Gujarat, India |
| Psychocare Health Private Limited | ₹40.92 Cr (FY 2024) | -22.0% | Mohali, Punjab, India | |||
| Seaconvert Private Limited | ₹40.92 Cr (FY 2025) | -40.0% | Ahmedabad, Gujarat, India | |||
| Goyal Ispat India Private Limited | ₹40.9 Cr (FY 2025) | -36.0% | Bangalore, Karnataka, India | |||
| D M Gattani Sons Private Limited | ₹40.9 Cr (FY 2024) | 7.0% | Janjgir, Chhattisgarh, India | |||
| Swati Mining Private Limited | ₹40.89 Cr (FY 2018) | -66.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Kashmik Formulation Private Limited, buy the company report.
Auditor
Kashmik Formulation Private Limited is audited by N Panchal And Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N Panchal And Associates | FY 2024 | 146175W |
Shareholding
The shareholding of Kashmik Formulation Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kashmik Formulation Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Feb 2023 | 100683747 | State Bank of India | ₹8.4 Cr | Open | |
| 16 Jun 2022 | 100612926 | State Bank of India | ₹20 Lakh | Open | |
| 26 Feb 2021 | 100428023 | State Bank of India | ₹18.1 Cr | Open |
To see the full charge records of Kashmik Formulation Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Kashmik Formulation Private Limited has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2023.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2023 | Rights issue | ₹5.28 Cr | Investors: 4 individuals |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 3 individuals |
| Jun 2020 | Rights issue | ₹3.49 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kashmik Formulation Private Limited has 15 court cases on record: 12 filed by Kashmik Formulation, 3 filed against it. 8 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 3 | 8 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Microlink Solutions Private Limited Through Bharatbhai Prajapati | Pending |
| Supreme Court | Court case (1807-Ordinary Civil Matters : Others) | Filed by the company against Nectar Biopharma Private Limited S/D/W/Thru:- N/A Through Secretary Having Office at 101, 1St Floor, Udyog Bhavan Sonawala Lane Goregaon East Mumbai ,Mumbai , Maharashtra and 1 other | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by Maruti Chemicals and Pharma Proprietor of Mettaliya Tusharbhai Kalubhai | Pending |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed against the company by M/S Champion Industry Through Proprietor Mr Dilip Chaudhary | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
To see the full case history of Kashmik Formulation Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kashmik Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kashmik Formulation Private Limited has a workforce of 22 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 22 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 |
To see the full employee and EPFO history of Kashmik Formulation Private Limited, buy the company report.
GST
Kashmik Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCN5830K1ZD | Gujarat | Active | 08 Sep 2017 |
To see the full GST registrations and return filing status of Kashmik Formulation Private Limited, buy the company report.
Recent activity
Kashmik Formulation Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Arunaben Mavjibhai Rajpara ceased to be Director on 31 Oct 2022.
Frequently asked questions
Kashmik Formulation is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 2017 (9+ years old) and is registered under CIN U24239GJ2017PTC095077.
Kashmik Formulation has 2 current directors:
- Mahadevbhai Naranbhai Patel - Director
- Nileshkumar Mahadevbhai Patel - Director
The latest financial statements of Kashmik Formulation on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Kashmik Formulation is 24AAFCN5830K1ZD, registered in Gujarat.
The CIN (Corporate Identification Number) of Kashmik Formulation is U24239GJ2017PTC095077. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kashmik Formulation has 15 court cases on record: 12 filed by the company and 3 filed against it. 8 are pending. Most are in the district courts.
Kashmik Formulation was incorporated on 11 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Kashmik Formulation has 3 deals on record (2 rights issues, 1 secondary share transfer); the latest was in January 2023.
The peers of Kashmik Formulation by revenue are Puyang Refractories Group Company India Private Limited, Daasarathy Enterprises Private Limited, Tripada Healthcare Private Limited, Anand Utilities Private Limited, Marica Agronomics Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Arunaben Mavjibhai Rajpara ceased to be Director on 31 Oct 2022. Mahadevbhai Naranbhai Patel was appointed as Director on 11 Jan 2017. Nileshkumar Mahadevbhai Patel was appointed as Director on 11 Jan 2017.
Yes, Kashmik Formulation is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

